The Clinical Research (CR) Forum, a Washington, D.C.-based nonprofit, has unveiled the 10 finalists in the running for its 2023 Clinical Research Achievement Award, which recognizes exceptional peer-reviewed, published trials.

The winning trials were selected based on their levels of novelty and innovation, contributions to the understanding of human disease and/or physiology, and potential effect on diagnosing, preventing and/or treating disease.

The forum will announce the winner April 17. Two others will earn additional recognition as distinguished awardees during the ceremony. The finalists are:

• Association of Bariatric Surgery with Cancer Risk and Mortality in Adults with Obesity (Ali Animian, director of Cleveland Clinic’s Bariatric and Metabolic Institute);
• Combination Therapy with 3BNC117 and 10-1074 in HIV-Infected Individuals (Tae-Wook Chun, chief of the National Institute of Allergy and Infectious Diseases’ HIV Immunovirology Section);
• Early COVID-19 Treatment with COVID-19 Convalescent Plasma (David Sullivan, professor of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health);
• Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults with Overweight in Real-life Settings: A Randomized Clinical Trial (Esra Tasali, director of the University of Chicago’s Sleep Center);
• Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study (David Nathan, director of Massachusetts General Hospital’s Diabetes Center);
• Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh (Jason Abaluck, professor of economics at Yale University’s School of Management);
• Maternal Asthma and Asthma Risk in Her Children (Kevin Magnaye, postdoctoral scholar at the University of Chicago’s Department of Human Genetics);
• Repeated Intravenous Cardiosphere-Derived Cell Therapy in Late-Stage Duchenne Muscular Dystrophy (HOPE-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial (Craig McDonald, chair of the department of physical medicine and rehabilitation at the Regents of the University of California Davis);
• Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali (Peter Crompton, chief of Malaria Infection Biology and Immunity at the National Institute of Allergy and Infectious Diseases); and
• Treating Hypertension during Pregnancy (Alan Tita, associate dean of global health at the University of Alabama at Birmingham’s Heersink School of Medicine).